96 related articles for article (PubMed ID: 2050332)
1. Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosis.
Desmorat H; Vinel JP; Lahlou O; Pipy B; Badia P; Cales P; Combis JM; Souqual MC; Pascal JP
Hepatology; 1991 Jun; 13(6):1181-4. PubMed ID: 2050332
[TBL] [Abstract][Full Text] [Related]
2. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis.
Vinel JP; Monnin JL; Combis JM; Calés P; Desmorat H; Pascal JP
Hepatology; 1990 Feb; 11(2):239-42. PubMed ID: 2307402
[TBL] [Abstract][Full Text] [Related]
4. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
5. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
[TBL] [Abstract][Full Text] [Related]
6. Effect of portacaval surgical anastomosis on systemic and splanchnic hemodynamics in portal hypertensive, cirrhotic rats.
Romeo JM; López-Farré A; Martín-Paredero V; López-Novoa JM
Can J Physiol Pharmacol; 1988 Dec; 66(12):1493-8. PubMed ID: 3228783
[TBL] [Abstract][Full Text] [Related]
7. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
[TBL] [Abstract][Full Text] [Related]
9. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415
[TBL] [Abstract][Full Text] [Related]
10. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
11. Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
Ruiz del Arbol L; García-Pagán JC; Feu F; Pizcueta MP; Bosch J; Rodés J
J Hepatol; 1991 Sep; 13(2):179-86. PubMed ID: 1744422
[TBL] [Abstract][Full Text] [Related]
12. Effects of carbon dioxide pneumoperitoneum on hemodynamics in cirrhotic rats.
Tsuboi S; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Baatar D
Surg Endosc; 2002 Aug; 16(8):1220-5. PubMed ID: 11984669
[TBL] [Abstract][Full Text] [Related]
13. Role of glucagon in the splanchnic and systemic hemodynamic changes induced by portal-systemic blood shunting.
Romeo JM; Lopez-Farre A; Martin-Paredero V; Lopez-Novoa JM
Clin Physiol Biochem; 1990; 8(3):144-52. PubMed ID: 2225722
[TBL] [Abstract][Full Text] [Related]
14. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
15. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
Nevens F; Pizcueta MP; Fernández M; Bosch J; Rodés J
Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867
[TBL] [Abstract][Full Text] [Related]
16. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
17. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
[TBL] [Abstract][Full Text] [Related]
18. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients.
Hadengue A; Lebrec D; Moreau R; Sogni P; Durand F; Gaudin C; Bernuau J; Belghiti J; Gayet B; Erlinger S
Hepatology; 1993 Feb; 17(2):175-8. PubMed ID: 8428714
[TBL] [Abstract][Full Text] [Related]
19. Splanchnic and systemic hemodynamic alterations in chronic, progressive portal hypertensive rats.
Blanchart A; Garrido MC; Fernández-Muñoz D; Nuño J; Hernando L; López-Novoa JM
Rev Esp Fisiol; 1984 Dec; 40(4):493-9. PubMed ID: 6397796
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
